A Telehealth-Based Randomized Controlled Trial: A Model for Outpatients Trials of Off-Label Medications During the COVID-19 Pandemic

Files
nihms-1690288.pdf (53.4 KB)
Date
2021-08
Authors
Keyhani, Salomeh
Kelly, J. Daniel
Bent, Stephen
Boscardin, W. John
Shlipak, Michael G.
Leonard, Sam
Abraham, Ann
Lum, Emily
Lau, Nicholas
Austin, Charles
Oldenburg, Catherine E.
Zillich, Allan
Lopez, Lenny
Zhang, Ying
Lietman, Tom
Bravata, Dawn M.
Language
American English
Embargo Lift Date
Department
Medicine, School of Medicine
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Sage
Abstract

The study was registered at clinicaltrials.gov: NCT04363203

Description
Keywords
Ambulatory care, Anti-bacterial agents, Azithromycin, COVID-19 drug treatment, Enzyme inhibitors, Hydroxychloroquine, SARS-CoV-2, Telemedicine, United States Department of Veterans Affairs
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Keyhani S, Kelly JD, Bent S, et al. A telehealth-based randomized controlled trial: A model for outpatient trials of off-label medications during the COVID-19 pandemic. Clin Trials. 2021;18(4):514-517. doi:10.1177/17407745211011577
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Clinical Trials
Rights
Publisher Policy
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
https://hdl.handle.net/1805/31487
DOI
https://doi.org/10.1177/17407745211011577
Version
Author's manuscript
Full Text Available at
This item is under embargo {{howLong}}
Collections
Open Access Coronavirus-Related Works
Department of Medicine Works
Open Access Policy Articles